Calumet (CLMT) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 May, 2026Executive summary
Q1 2026 was strategically pivotal, with strong margin environments in both traditional and renewable energy markets, despite operational downtime at Shreveport and planned expansion work in Montana limiting full margin capture.
Adjusted EBITDA with Tax Attributes was $50.1 million, down from $55 million in Q1 2025, impacted by Shreveport production loss but offset by specialty price increases and record TruFuel sales.
Montana Renewables completed the MaxSAF 150 expansion and turnaround, resuming operations in May and positioning for increased SAF production.
EPA's Set 2 RVO announcement in March 2026 reset the outlook for the biofuels industry, supporting strong, stable margins and incentivizing industry utilization growth.
Reported a net loss of $317.0 million for Q1 2026, primarily due to non-cash RINs and mark-to-market items.
Financial highlights
Generated $50.1 million of adjusted EBITDA in Q1 2026, down from $55 million in Q1 2025, primarily due to operational issues at Shreveport.
Specialty Products and Solutions segment delivered $44.3 million of adjusted EBITDA, compared to $56.3 million in Q1 2025.
Performance Brands reported $12.6 million of adjusted EBITDA, with record TruFuel sales volume.
Montana Renewables segment posted $10.2 million of adjusted EBITDA with Tax Attributes, up from $3.3 million in Q1 2025.
Net income (loss) for Q1 2026 was $(317.0) million, with significant non-cash expenses including $147.4 million RINs and $102.7 million unrealized derivative loss.
Outlook and guidance
Expectation of a strong Q2 with additional cash flow generation, supported by price increases and elevated fuel margins.
SET2 RVO finalized in March 2026 supports robust renewable diesel and SAF demand, correcting prior regulatory shortfalls.
Renewables business at a positive inflection point, with a 4-5x increase in SAF volumes anticipated on an annual run rate basis.
No change in the plan to eventually monetize Montana Renewables; focus remains on demonstrating earnings power post-expansion.
Positioned to accelerate deleveraging and pursue long-term growth as operational improvements take effect.
Latest events from Calumet
- Adjusted EBITDA up 30% to $293.3M, $222M debt cut, and record specialty output achieved.CLMT
Q4 20257 Apr 2026 - Expanding SAF production and strong cash flow drive growth, supported by regulatory tailwinds.CLMT
H.C. Wainwright Renewables Fuels Virtual Day presentation25 Mar 2026 - Q2 2024 delivered $66.8M EBITDA, record volumes, and C-Corp conversion amid margin pressure.CLMT
Q2 20241 Feb 2026 - Record SAF output, $1.44B DOE loan, and $150M sale-leaseback drive growth and liquidity.CLMT
Q3 202415 Jan 2026 - DOE loan enables major SAF expansion, debt reduction, and strategic growth for renewables.CLMT
Status Update10 Jan 2026 - Unitholders to vote on conversion to a corporation, exchanging units for shares and warrants.CLMT
Proxy Filing2 Dec 2025 - C-Corp conversion, DOE loan, and asset sale drive deleveraging and renewables growth.CLMT
Q4 20241 Dec 2025 - Q2 2025 posted a $147.9M loss, but cost cuts and specialty gains drove operational progress.CLMT
Q2 202523 Nov 2025 - Q1 2025 net loss deepened, but EBITDA, liquidity, and SAF expansion advanced.CLMT
Q1 202520 Nov 2025